# $dbvt

Biopharm Catalyst reports Upstream Bio's Phase [--] VALIANT trial for verekitug in severe asthma shows significant positive results. The trial demonstrated substantial reductions in exacerbation rates and improvements in lung function.

### About $dbvt
$DBVT is a decentralized digital currency and its associated ecosystem.  

### Top $dbvt Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$UPB reported Phase [--] VALIANT trial results for verekitug in severe asthma showing statistically significant reductions in exacerbation rates (up to 56%) and meaningful improvements in lung function and FeNO across key dosing regimens. $UPB $QNCX $STIM $ELAB $BFRI $MRNA $HURA $PHIO $AIM $DBVT See More Pre-market Movers https://www.biopharmcatalyst.com/news/2026/upstream-bio-upb-phase-2-data-quince-qncx-strategic-alternatives https://www.biopharmcatalyst.com/news/2026/upstream-bio-upb-phase-2-data-quince-qncx-strategic-alternatives"  
[X Link](https://x.com/BPharmCatalyst/status/2021580039637074077) [@BPharmCatalyst](/creator/x/BPharmCatalyst) 2026-02-11T13:40Z 30.7K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing